We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 81,789

GSK and Novartis are in hot water for mislabelling Voltaren Osteo Gel to charge price premium
  • Cordato Partners
  • Australia
  • December 14 2017

Fresh from its success in the Nurofen Specific Pain products proceedings, the Australian Competition & Consumer Commission (ACCC) is looking for a


House of Representatives reintroduces resident rotator legislation
  • Dentons
  • USA
  • December 14 2017

On December 5, members of the US House of Representatives reintroduced a bipartisan bill designed to help hospitals that accidentally established


Disability Discrimination: reasonable requirements v reasonable adjustments
  • Lander & Rogers
  • Australia
  • December 13 2017

A Full Court of the Federal Court of Australia has upheld the decision of a trial judge that the Australian College of Dermatologists did not directly


2018 Reimbursement Cuts for Some Off-Campus Hospital Provider-Based Departments
  • McGuireWoods LLP
  • USA
  • December 13 2017

On Nov. 2, 2017, the Centers for Medicare and Medicaid Services (CMS) finalized a rule changing reimbursement rates under the Medicare Physician Fee


Trade Group Sues State of California to Block S.B. 17 Drug Pricing Bill
  • Quarles & Brady LLP
  • USA
  • December 13 2017

As an update to a recent Health Law Alert ("California Passes Two Drug Pricing Transparency Laws," 112017), we learned that on December 8, 2017


Draft Fee Regulations - Attempts to Address Incentivising Loopholes
  • Hogan Lovells
  • South Africa
  • December 13 2017

Section 18A of the South African Medicines Act (the “Medicines Act“) prohibits the supply of any medicine, medical device or in-vitro diagnostic


Producteurs de cannabis : importants changements à venir aux licences et permis de Santé Canada
  • Langlois Lawyers LLP
  • Canada
  • December 13 2017

En novembre 2017, Santé Canada publiait pour consultation un important document intitulé Approche proposée en matière de la réglementation du


Canadian reporting issuers with U.S.-related cannabis activities
  • Dickinson Wright
  • USA, Canada
  • December 13 2017

The House of Commons has passed the third reading related to the Cannabis Act (the “Act”). Scheduled to come into force no later than July 2018


Digital Health Care Investors Summit Highlights Digital Health Expansion
  • Foley & Lardner LLP
  • USA
  • December 13 2017

In early December, leading experts in digital health and telemedicine came together at the Digital Health Care Investors Summit hosted by Foley &


White Collar Courier: Delivering News and Providing Guidance in White Collar Matters
  • Burr & Forman LLP
  • USA
  • December 13 2017

In Part One of this series, I detailed how the U.S. Department of Justice has focused its attention on the aggressive investigation and prosecution